Stock Research for GTXI

GTXI

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

GTXI Stock Chart & Research Data

The GTXI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GTXI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


GTXI Due diligence Resources & Stock Charts

The GTXI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View GTXI Detailed Price Forecast - CNN Money CNN View GTXI Detailed Summary - Google Finance
Yahoo View GTXI Detailed Summary - Yahoo! Finance Zacks View GTXI Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View GTXI Trends & Analysis - Trade-Ideas Barrons View GTXI Major Holders - Barrons
NASDAQ View GTXI Call Transcripts - NASDAQ Seeking View GTXI Breaking News & Analysis - Seeking Alpha
Spotlight View GTXI Annual Report - CompanySpotlight.com OTC Report View GTXI OTC Short Report - OTCShortReport.com
TradeKing View GTXI Fundamentals - TradeKing Charts View GTXI SEC Filings - Bar Chart
WSJ View Historical Prices for GTXI - The WSJ Morningstar View Performance/Total Return for GTXI - Morningstar
MarketWatch View the Analyst Estimates for GTXI - MarketWatch CNBC View the Earnings History for GTXI - CNBC
StockMarketWatch View the GTXI Earnings - StockMarketWatch MacroAxis View GTXI Buy or Sell Recommendations - MacroAxis
Bullish View the GTXI Bullish Patterns - American Bulls Short Pains View GTXI Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View GTXI Stock Mentions - StockTwits PennyStocks View GTXI Stock Mentions - PennyStockTweets
Twitter View GTXI Stock Mentions - Twitter Invest Hub View GTXI Investment Forum News - Investor Hub
Yahoo View GTXI Stock Mentions - Yahoo! Message Board Seeking Alpha View GTXI Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for GTXI - SECform4.com Insider Cow View Insider Transactions for GTXI - Insider Cow
CNBC View GTXI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for GTXI - OTC Markets
Yahoo View Insider Transactions for GTXI - Yahoo! Finance NASDAQ View Institutional Holdings for GTXI - NASDAQ


Stock Charts

FinViz View GTXI Stock Insight & Charts - FinViz.com StockCharts View GTXI Investment Charts - StockCharts.com
BarChart View GTXI Stock Overview & Charts - BarChart Trading View View GTXI User Generated Charts - Trading View




Latest Financial News for GTXI


Lifshitz & Miller LLP Announces Investigation of Amarin Corporation plc, Clementia Pharmaceuticals Inc., CVS Health Corporation, Diplomat Pharmacy, Inc., GTx, Inc., Multi-Color Corporation, Osiris Therapeutics, Inc., and The Kraft Heinz Company
Posted on Friday March 22, 2019

NEW YORK , March 22, 2019 /PRNewswire/ -- Amarin Corporation plc (AMRN) Lifshitz & Miller  announces investigation into possible securities laws violations in connection with allegations that Amarin administered ...


Editorial: GTx's fall is not a failure
Posted on Friday March 22, 2019

Entrepreneurs of all types strive to create new solutions to old problems, and that always comes with risk of failure — and not just with untested drugs. One shouldn’t stop striving to create something new, no matter the industry, just because it might not work out.


Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Clementia, Multi-Color, and GTx on Behalf of Stockholders and Encourages Investors to Contact the Firm
Posted on Wednesday March 20, 2019

NEW YORK, March 20, 2019 -- Bragar Eagel & Squire, P.C. reminds investors that it is investigating potential claims on behalf of stockholders of Clementia Pharmaceuticals.


GTx's legacy: The once-promising pillar of Memphis' 'biotech core'
Posted on Wednesday March 13, 2019

“We had a commercial team, a marketing team, and the sales organization. … At the last minute, the FDA decided the data was not sufficient for approval.”


Stock Market & Investing Books

Enter a stock symbol to view the stock details.